AbbVie inks $700M deal with IGI for multiple myeloma trispecific antibodynews2025-07-10T15:30:12+00:00July 10th, 2025|Endpoints News|
Aqtual raises $31M to guide rheumatoid arthritis treatmentsnews2025-07-10T07:00:13+00:00July 10th, 2025|Endpoints News|
Revolution and Iambic sign AI R&D deal for cancer drugsnews2025-07-09T12:00:19+00:00July 9th, 2025|Endpoints News|
Merck to buy respiratory drugmaker Verona Pharma for $10Bnews2025-07-09T11:01:58+00:00July 9th, 2025|Endpoints News|
Quanterix closes $127M Akoya deal after competing bidnews2025-07-08T13:10:44+00:00July 8th, 2025|Endpoints News|
Shell company Concentra has found its rhythm, with Cargo Therapeutics as its latest buyout targetnews2025-07-08T11:25:01+00:00July 8th, 2025|Endpoints News|
Roche-backed Chugai taps into longevity field with Pfizer-allied Geronews2025-07-07T07:00:46+00:00July 7th, 2025|Endpoints News|
Sage talked to 43 ‘counterparties’ before inking Supernus dealnews2025-07-03T11:23:15+00:00July 3rd, 2025|Endpoints News|
Shionogi, BioVersys team up on ansamycin antibiotics in deal worth up to $614Mnews2025-07-02T05:00:50+00:00July 2nd, 2025|Endpoints News|
Kevin Tang’s Concentra snags another buyout, this time for IGM Biosciencesnews2025-07-01T14:22:39+00:00July 1st, 2025|Endpoints News|
